• 中国精品科技期刊
  • 中国高校百佳科技期刊
  • 中国中文核心期刊
  • 中国科学引文数据库核心期刊
Advanced Search
Advances in the research of factor Xa inhibitors[J]. Journal of China Pharmaceutical University, 2010, 41(2): 104-111.
Citation: Advances in the research of factor Xa inhibitors[J]. Journal of China Pharmaceutical University, 2010, 41(2): 104-111.
shu

Advances in the research of factor Xa inhibitors

More Information
    Graphical Abstract
    • Abstract
  • Factor Xa is a trypsin-like serine protease playing a pivotal role in the blood coagulation cascade.Factor Xa and its inhibitors are of great importance in the development of orally active antithrombotic agents and have aroused considerable attention from the pharmaceutical industry sector over the years.In this review，the structural characteristics of the factor Xa binding site are discussed and the X-ray information available together with the published structure-activity relationship data is used to identify the molecular interactions that are most important for tight enzymeinhibitor binding，which would be useful in the structurebased drug design of novel factor Xa inhibitors.
    • FullText(HTML)
    • References (0)
    • Related Articles

  • Related Articles

    [1]YANG Qian, WANG Xiaojian. Research progress of sphingosine kinase 1 inhibitors[J]. Journal of China Pharmaceutical University, 2021, 52(6): 759-768. DOI: 10.11665/j.issn.1000-5048.20210615
    [2]ZHANG Wanyue, LIU Wei, XU Hang, GAO Xiangdong. Advanced structure analysis and structure-activity relationship of polysaccharide SGP-2 from Sarcandra glabra[J]. Journal of China Pharmaceutical University, 2021, 52(5): 630-635. DOI: 10.11665/j.issn.1000-5048.20210517
    [3]GUO Yahui, LU Peng, WANG Yubin, ZHANG Huibin. Progress in the researches for antitumor NEDD8 activating enzyme inhibitors[J]. Journal of China Pharmaceutical University, 2017, 48(6): 646-653. DOI: 10.11665/j.issn.1000-5048.20170603
    [4]CHEN Ming, XIE Zhouling, LI Tinghan, WEI Zhihui, ZHAO Lu, LI Zhiyu. Advances in research on a novel antitumor target CDK9 and its inhibitors[J]. Journal of China Pharmaceutical University, 2017, 48(2): 233-241. DOI: 10.11665/j.issn.1000-5048.20170216
    [5]MO Xianwei, ZHANG Lei, GUAN Su, YAN Jinwu, LI Jing. Advances in antidepressants based on the regulation of serotonin receptors[J]. Journal of China Pharmaceutical University, 2016, 47(6): 639-647. DOI: 10.11665/j.issn.1000-5048.20160602
    [6]XIN Minhang, ZHANG Sanqi. Advances in PI3Kδ selective inhibitors[J]. Journal of China Pharmaceutical University, 2016, 47(5): 503-510. DOI: 10.11665/j.issn.1000-5048.20160501
    [7]ZHANG Shengmiao, SUN Haopeng, JIA Jianmin, XU Xiaoli, YOU Qidong. Advances on indenoisoquinoline compounds with antitumor activities[J]. Journal of China Pharmaceutical University, 2013, 44(6): 589-595. DOI: 10.11665/j.issn.1000-5048.20130620
    [8]LIU Haomiao, HU Xiaowen, ZHOU Jinpei, ZHANG Huibin. Advances of G protein coupled receptor 119 agonists and their structure-activity relationship[J]. Journal of China Pharmaceutical University, 2013, 44(1): 11-19. DOI: 10.11665/j.issn.1000-5048.20130102
    [9]ZHENG Kai-bo, SUN Cheng-bin, MAO Hai-li, YANG Zai-bo. Progress in the research of chemical structural modification of ursolic acid and structure-activity relationship[J]. Journal of China Pharmaceutical University, 2009, 40(6): 580-584.
    [10]Advances in Selective COX-2 Inhibitors[J]. Journal of China Pharmaceutical University, 2003, (3): 1-6.

Catalog

    Get Citation
    PDF
    XML
    Article views (3506) PDF downloads (4065) Cited by()
    Turn off MathJax
    Article Contents
    Abstract
    Related Articles

    Copyright © Journal of China Pharmaceutical University苏ICP备12050101号-2

    Address：24 Tongjia Lane, Nanjing City, Jiangsu Province （210009）Tel: 025-83271566E-mail: xuebao@cpu.edu.cn

    Supported by: Beijing Renhe Information Technology Co., Ltd.  Baidu Analytics

    Total visits：284996

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return